Halozyme Therapeutics reported $233.3M in Trade Debtors for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Debtors Change
DBV Technologies DBVT:US USD 8.92M 710K
Acadia Pharmaceuticals ACAD:US USD 56.14M 12.75M
Agios Pharmaceuticals AGIO:US USD 5.59M 1.29M
Alnylam Pharmaceuticals ALNY:US USD 184.51M 42.24M
Amarin AMRN:US USD 123.38M 20.56M
Amgen AMGN:US USD 5.56B 237M
Baxter International BAX:US USD 2.56B 82M
Cara Therapeutics CARA:US USD 10.77M 1.6M
Cytokinetics CYTK:US USD 2.29M 321K
Esperion Therapeutics ESPR:US USD 31.49M 3.64M
Halozyme Therapeutics HALO:US USD 233.3M 43.93M
Immunogen IMGN:US USD 4.19M 1.76M
Intercept Pharmaceuticals ICPT:US USD 26.17M 1.35M
Intra Cellular Therapies ITCI:US USD 61.54M 14.56M
Intrexon XON:US USD 2.45M 583K
IONIS PHARMACEUT IONS:US USD 6.64M 106K
JAZZ PHA JAZZ:US USD 601.18M 7.14M
Mannkind MNKD:US USD 23.49M 8.46M
Nektar Therapeutics NKTR:US USD 11.53M 1.53M
Peregrine Pharmaceuticals PPHM:US USD 27.11M 5.92M
Rigel Pharmaceuticals RIGL:US USD 15.52M 1.67M
United Therapeutics UTHR:US USD 231.7M 58.3M
Vanda Pharmaceuticals VNDA:US USD 29.35M 547K